Steven Cohen Ocugen, Inc. Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.62 $19,812 - $30,709	-49,531 Reduced 59.06%	34,341 $13,000
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.88 $33,809 - $66,117	-75,133 Reduced 47.25%	83,872 $45,000
Q1 2023 May 15, 2023	BUY	$0.82 - $1.33 $130,384 - $211,476	159,005 New	159,005 $135,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $173M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.